Title : Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia.

Pub. Date : 2017 May

PMID : 28152223






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inotuzumab ozogamicin (IO), a CD22-targeted antibody-drug conjugate demonstrated impressive single agent activity even among heavily pretreated relapsed B-ALL patients. io CD22 molecule Homo sapiens